[{"NetIncomeLoss_1_Q1_USD":-45933000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":-6000.0,"MinorityInterestDecreaseFromRedemptions_1_Q1_USD":64000.0,"OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax_1_Q1_USD":4749000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":16148000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":143112000.0,"InterestAndOtherIncome_1_Q1_USD":625000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":-6000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":13760000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":714000.0,"RestrictedCashAndCashEquivalentsNoncurrent_0_Q1_USD":1500000.0,"OperatingLeaseLiability_0_Q1_USD":42345000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":45289000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":31000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":7237000.0,"AssetsCurrent_0_Q1_USD":606944000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":17614376.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":-416000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":7089000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":506540000.0,"Assets_0_Q1_USD":877095000.0,"ShareBasedCompensation_1_Q1_USD":7524000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":70324000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":15651000.0,"ContractualObligation_0_Q1_USD":17961000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":44000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":1818000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":4663000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":56434000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":53325000.0,"MinorityInterest_0_Q1_USD":-938000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-328000.0,"LettersOfCreditOutstandingAmount_0_Q1_USD":1500000.0,"AccountsReceivableNetCurrent_0_Q1_USD":6746000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":262000.0,"CommonStockValue_0_Q1_USD":1437000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q1_USD":42431000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-3829000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":800000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":1875000.0,"AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost_0_Q1_USD":464109000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":15235000.0,"IncomeLossIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-45677000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-50638000.0,"AccruedEmployeeBenefitsCurrent_0_Q1_USD":13077000.0,"OtherAssetsNoncurrent_0_Q1_USD":14097000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":122975000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":38463000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":1292118000.0,"GoodwillAndIntangibleAssetImpairment_1_Q1_USD":0.0,"Liabilities_0_Q1_USD":407678000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_1_Q1_USD":-7561000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":-20047000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":15651000.0,"AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost_0_Q1_USD":42431000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1522000.0,"RestrictedCashNoncurrent_0_Q1_USD":1500000.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":97935000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_1_Q1_USD":-61000.0,"PaymentsToAcquireAdditionalInterestInSubsidiaries_1_Q1_USD":65000.0,"ProceedsFromSaleOfHeldToMaturitySecurities_1_Q1_USD":6870000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":124000.0,"Goodwill_0_Q1_USD":40994000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":2234000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":7524000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-4749000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-8354000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-68550000.0,"LiabilitiesCurrent_0_Q1_USD":132839000.0,"AccountsPayableCurrent_0_Q1_USD":11638000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":124475000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":12140000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":55583000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.062,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":469417000.0,"OperatingLeasePayments_1_Q1_USD":1700000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":6870000.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":2953000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":45222000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":6991000.0,"InterestReceivableCurrent_0_Q1_USD":974000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-823914000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_1_Q1_USD":-824000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":10980000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":7308000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":1741000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":26280000.0,"ImpairmentOfLongLivedAssetsHeldForUse_1_Q1_USD":0.0,"OperatingIncomeLoss_1_Q1_USD":-46302000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities_1_Q1_USD":144369000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_1_Q1_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":464109000.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":94364000.0,"PreferredStockValue_0_Q1_USD":0.0,"VariableLeaseCost_1_Q1_USD":700000.0,"OperatingLeaseCost_1_Q1_USD":2700000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":7524000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":3882000.0,"OperatingExpenses_1_Q1_USD":72582000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":1356000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.32,"ProfitLoss_1_Q1_USD":-45939000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":7228000.0,"StockholdersEquity_0_Q1_USD":470355000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q1_USD":222278000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":7950000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":506447000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":877095000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":-50644000.0,"Ticker":"SGMO","CIK":"1001233","name":"SANGAMO THERAPEUTICS, INC","OfficialName":"Sangamo Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"750923571.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210504"}]